EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview

Sang Heon Suh, Soo Wan Kim

Diabetes & Metabolism Journal · 30.09.2023 · 47 (5) · 612-629

DOI: 10.4093/dmj.2023.0067 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 30.09.2023. Verfasst von Sang Heon Suh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Dyslipidemias. Die Arbeit wurde bisher 129-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Chonnam National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dyslipidemia is a potentially modifiable cardiovascular risk factor. Whereas the recommendations for the treatment target of dyslipidemia in the general population are being more and more rigorous, the 2013 Kidney Disease: Improving Global Outcomes clinical practice guideline for lipid management in chronic kidney disease (CKD) presented a relatively conservative approach with respect to the indication of lipid lowering therapy and therapeutic monitoring among the patients with CKD. This may be largely attributed to the lack of high-quality evidence derived from CKD population, among whom the overall feature of dyslipidemia is considerably distinctive to that of general population. In this review article, we cover the characteristic features of dyslipidemia and impact of dyslipidemia on cardiovascular outcomes in patients with CKD. We also review the current evidence on lipid lowering therapy to modify the risk of cardiovascular events in this population. We finally discuss the association between dyslipidemia and CKD progression and the potential strategy to delay the progression of CKD in relation to lipid lowering therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicDyslipidemiasHumansHeartHeart Disease Risk FactorsLipids

Stichwörter der Autor:innen

DyslipidemiasKidney diseasesRisk

Substanzen

Lipids

Autor:innen und Institutionen

  • Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT
  • Chonnam National University

Zitieren

APA

Suh, S. H., & Kim, S. W. (2023). Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview. Diabetes & Metabolism Journal, 47(5), 612-629. https://doi.org/10.4093/dmj.2023.0067

Vancouver

Suh SH, Kim SW. Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview. Diabetes & Metabolism Journal. 2023;47(5):612-629. doi:10.4093/dmj.2023.0067

BibTeX
@article{Suh2023,
  author = {Suh, Sang Heon and Kim, Soo Wan},
  title = {Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview},
  journal = {Diabetes & Metabolism Journal},
  year = {2023},
  volume = {47},
  number = {5},
  pages = {612--629},
  doi = {10.4093/dmj.2023.0067}
}
Kostenlos starten →